Atopic dermatitis (AD) has a substantial disease burden due to its high prevalence, chronicity, and impact on quality of life (QoL). 1 Despite the recognition of the widespread impact of AD, Canadian literature on the subject matter is sparse. In November and December 2016, the Eczema Society of Canada (ESC) conducted an online national cross-sectional survey to assess the burden of self-reported moderate to severe atopic dermatitis for adult patients living in Canada. Participants were recruited through direct email invitation, an electronic newsletter, and social media. The survey specifically assessed QoL, treatments used, and access to care in Canada. Results of this survey were originally published in a lay report by the ESC, and here we present some of the notable results for a medical audience. 2 Data tables and figures are provided in the online supplement. We had 377 initial respondents to our survey, the majority from Ontario (147/377, 39%) and Quebec (84/377, 22%), 246 of whom met inclusion criteria by living in Canada and having or caring for someone with moderate or severe atopic dermatitis. Atopic dermatitis had a substantial impact on the QoL: 87% (187/216) of respondents reported their daily life was negatively affected by their disease. The most common negative experiences reported were dysfunctional sleep (148/187, 79%), anxiety (120/187, 64%), avoidance of social activities (90/187, 48%), avoidance of physical activity (88/187, 47%), and avoidance of intimacy (75/187, 40%). Many respondents also reported difficulty accessing specialty care and appropriate treatments. Nearly one-third (62/193, 32%) reported having difficulty in accessing treatment, and 41% (80/193) felt their treatment needs were unmet. While AD is typically managed by primary care physicians, patients with moderate to severe disease often require dermatological consultation. Among respondents reporting moderate to severe AD, only 42% were managed by a dermatologist. Survey participants shared challenges and frustration with accessing a dermatologist in their local area, accessing a dermatologist in a timely manner, and, for some, accessing a dermatologist at all. For patients seeing a dermatologist, wait times are long, with 69% (111/160) having to wait more than Medical Letter 758992C MSXXX10.